| Name | Title | Contact Details |
|---|
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte`s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte`s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA`s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense.
Acusphere, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Cambridge, MA. To find more information about Acusphere, Inc., please visit www.acusphere.com
Sectra North America is a Shelton, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OneOncology is a partnership of independent community oncology practices committed to driving the future of cancer care delivery through a patient-centric, physician-driven, and technology-powered model to help improve the lives of everyone living with cancer. OneOncology empowers community oncology practices by supporting the entire continuum of care, including prevention and diagnosis, research and treatment, and long-term survivorship, palliative, and hospice care. Our technology is powered by the Flatiron suite of services to provide access to key clinical and operational data and the latest research via a cloud-based network. This comprehensive approach supports community oncologists` transition to value-based care and commitment to providing their patients with access to best-in-class healthcare, close to home. For OneOncology, cancer is personal, and the mission is critical. Working together with world class oncologists, OneOncology looks to drive the change that community cancer needs through continual learning, creative and smart evolution, and a collective desire to positively impact the lives of every person touched by cancer.
Healthcare Bluebook`s goal is to protect consumers and companies nationwide from overpriced, low-quality healthcare. Using industry-leading objective price and quality data and claims-driven ROI reporting, Bluebook`s intuitive online healthcare shopping solution provides 7,000+ employers and members with an easy-to-use benefits solution that increases movement to high-value care, driving savings and rapid ROI, and provides greater price predictability. Combined with a proven engagement methodology, Bluebook`s innovative suite of services empowers employees to become smarter healthcare shoppers, while decreasing costs and improving healthcare outcomes.